Citation:Kong G, Johnston V, Ramdave S, Lau E, Rischin D, Hicks RJ 2009

From Clinical Guidelines Wiki

Citation


Kong G, Johnston V, Ramdave S, Lau E, Rischin D, Hicks RJ. High-administered activity In-111 octreotide therapy with concomitant radiosensitizing 5FU chemotherapy for treatment of neuroendocrine tumors: preliminary experience. Cancer Biother Radiopharm 2009 Oct;24(5):527-33 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/19877882.



Critical appraisals


Compare quality appraisals for each clinical question

Cited by

  1. NETs guidelines/Radionuclide Therapy